Health Secretary Wes Streeting expressed gratitude for the opportunity to meet former Little Mix member Jesy Nelson, commending her for sharing her personal story. Nelson met with Streeting to advocate for the implementation of newborn screening for spinal muscular atrophy (SMA), a condition her twin babies have been diagnosed with, preventing them from walking.
The Mirror is campaigning for the addition of a simple £5 SMA check to the NHS newborn heel prick test, aiming to enable early treatment and potential cure before irreversible nerve damage occurs in infants. Streeting acknowledged Nelson’s bravery in discussing her family’s journey, emphasizing the hope and comfort her openness may provide to other families facing similar challenges.
During the meeting with Streeting, Nelson and the charity SMA UK highlighted the critical importance of early diagnosis due to the severe consequences of delayed detection. The advocacy for expanded newborn screening for SMA in the UK aligns with efforts in other European countries where SMA screening at birth is routine.
Novartis, a pharmaceutical company, estimated that 33 UK babies annually experience delayed diagnosis, leading to mobility issues. Zolgensma, a gene therapy available through the NHS, offers a one-time treatment that can preserve essential functions like sitting, crawling, and walking if administered early enough to prevent muscle neuron loss in the first weeks of life.
Rob Hastings, chief medical officer at Novartis UK, praised Nelson for sharing her children’s SMA experience and urged the government to enhance newborn screening nationwide. Late diagnosis of severe SMA types often results in significant disabilities, necessitating extensive medical support for affected children.
Nelson’s public disclosure of her twins’ diagnosis prompted Streeting to advocate for improved screening and genomic medicine utilization. The urgency for early intervention in SMA cases is underscored by the rapid muscle deterioration observed in infants without treatment.
Nelson’s emotional account on This Morning detailed her realization of her twins’ declining mobility and the frustration of knowing that timely treatment could have made a difference. Her poignant narrative highlights the importance of proactive healthcare measures to prevent irreversible damage in SMA-affected infants.
By prioritizing expanded newborn screening and timely interventions for SMA, stakeholders aim to improve outcomes for affected children and reduce the burden of late diagnoses on families.